14 results
20-F
2014 FY
ENLV
Enlivex Therapeutics Ltd
31 Mar 15
Annual report (foreign)
12:00am
if such candidate meets certain independence criteria, the terms are in line with the Compensation Policy and the Compensation Committee has determined … are similar such that it would generally be expected that our two external directors will also comply with the independence requirement under
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
nominees, our Board of Directors will consist of six members, five of whom satisfy the independence requirements of the Nasdaq Listing Rules.
We believe
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
the independence requirements of the Nasdaq Listing Rules.
Our Nominating Committee reviewed the qualifications and suitability of each of the director nominees
424B4
ENLV
Enlivex Therapeutics Ltd
31 Jul 14
Prospectus supplement with pricing info
12:00am
, including (among others) the composition and responsibilities of the audit committee and the independence of its members within the meaning of the rules … with the independence requirement under the NASDAQ Stock Market rules. The definition of an external director includes a set of statutory criteria (which are described
F-1/A
dob3zrol9 l5qz5uuvy
8 Jul 14
Registration statement (foreign) (amended)
12:00am
20-F/A
a3j7ixfjnxfeno
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
EX-1.1
z8atl4mwc2 xwuwz
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
- Prev
- 1
- Next